EUVIMEDEUVIMED entdecken
Crossref

Extracellular HMGB1 impairs macrophage phagocytosis and promotes salivary gland dysfunction in Sjogren’s syndrome

Bingxia Ming iD, Ling Li, Yuanji Dong, Xuefen Wu, Rongfen Gao, Jixin Zhong iD, Lingli Dong iD

The Journal of Immunology · 2025

DOI: 10.1093/jimmun/vkaf225 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, 2025. Verfasst von Bingxia Ming und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, Chin…. Hauptthemen laut MEDLINE: HMGB1 Protein, Sjogren's Syndrome, Phagocytosis, Salivary Glands. Die Arbeit nennt 55 Literaturangaben. Gefördert von: National Natural Scientific Foundation of China, Tongji Hospital Clinical Research Flagship Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Impaired phagocytosis of macrophages was observed in the salivary glands (SGs) of Sjogren’s syndrome (SS). This study aims to investigate the dynamic changes of extracellular high mobility group box 1 (HMGB1) within these tissue microenvironments and its roles in macrophage function and subsequent gland dysfunction in SS. Our study detected a gradual increase in the expression and extracellular translocation of HMGB1 in the SGs of SS. Notably, this increased HMGB1 expression was negatively correlated with saliva associated AQP5 expression. Furthermore, elevated macrophages predominantly located around the duct, acinar, and infiltrate foci within the SGs expressed Toll-like receptor 4 and showed an M1 phenotype. Recombinant HMGB1 stimulation resulted in increased expression of major histocompatibility complex class II and a reduced phagocytic capacity of macrophages in vitro. Moreover, treatment with glycyrrhizin, a natural HMGB1 inhibitor, led to a significant improvement of saliva flow rates and a reduction of inflammatory cell infiltration and autoantibody levels when compared with phosphate-buffered saline–treated SS-like NOD/ShiLtJ mice. Our findings demonstrate that extracellular HMGB1 exacerbates the inflammatory-autoimmune microenvironments in SGs, suggesting that glycyrrhizin treatment may serve as a promising natural inhibitor for the management of SS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HMGB1 ProteinSjogren's SyndromePhagocytosisSalivary GlandsMacrophagesAnimalsMiceHumansFemaleMice, Inbred NODAquaporin 5Middle AgedGlycyrrhizic AcidToll-Like Receptor 4SalivaDisease Models, Animal

Stichwörter der Autor:innen

HMGB1Sjogren’s syndromeglycyrrhizinmacrophage

Substanzen

HMGB1 ProteinAquaporin 5Glycyrrhizic AcidHMGB1 protein, humanToll-Like Receptor 4

Autor:innen und Institutionen

  • Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

ORCID-Profile: Bingxia Ming, Jixin Zhong, Lingli Dong

Förderung

  • National Natural Scientific Foundation of China
  • Tongji Hospital Clinical Research Flagship Program

Zitieren

APA

Ming, B., Li, L., Dong, Y., Wu, X., Gao, R., Zhong, J., & Dong, L. (2025). Extracellular HMGB1 impairs macrophage phagocytosis and promotes salivary gland dysfunction in Sjogren’s syndrome. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkaf225

Vancouver

Ming B, Li L, Dong Y, Wu X, Gao R, Zhong J, et al. Extracellular HMGB1 impairs macrophage phagocytosis and promotes salivary gland dysfunction in Sjogren’s syndrome. The Journal of Immunology. 2025. doi:10.1093/jimmun/vkaf225

BibTeX
@article{Ming2025,
  author = {Ming, Bingxia and Li, Ling and Dong, Yuanji and Wu, Xuefen and Gao, Rongfen and Zhong, Jixin and Dong, Lingli},
  title = {Extracellular HMGB1 impairs macrophage phagocytosis and promotes salivary gland dysfunction in Sjogren’s syndrome},
  journal = {The Journal of Immunology},
  year = {2025},
  doi = {10.1093/jimmun/vkaf225}
}
Kostenlos starten →